Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient-Reference-Cited by-同舟云学术

Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient

Published:2018-08 Issue: Volume:121 Page:256-265
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Kuramoto Yuki,Naito Atsuhiko T.,Tojo Hiromasa,Sakai Taku,Ito Masamichi,Shibamoto Masato,Nakagawa Akito,Higo Tomoaki,Okada Katsuki,Yamaguchi Toshihiro,Lee Jong-Kook,Miyagawa Shigeru,Sawa Yoshiki,Sakata Yasushi,Komuro Issei

Funder

Research and Development

Japan Foundation for Applied Enzymology

Takeda Science Foundation

School of Medicine

Osaka University

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference43 articles.

1. α-Galactosidase A deficiency: Fabry disease;Desnick,2014

2. Fabry disease;Germain;Orphanet J. Rare Dis.,2010

3. Evolution of cardiac pathology in classic Fabry disease: progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy;Frustaci;Int. J. Cardiol.,2017

4. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry;Waldek;Genet. Med.,2009

5. Cardiovascular events in patients with Fabry disease: natural history data from the Fabry Registry;Patel;J. Am. Coll. Cardiol.,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we use stem cell-derived cardiomyocytes to understand the involvement of energetic metabolism in alterations of cardiac function?;Frontiers in Molecular Medicine;2023-09-01

2. Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives;Regulatory Mechanisms in Biosystems;2023-08-28

3. Modeling Reduced Contractility and Stiffness Using iPSC-Derived Cardiomyocytes Generated From Female Becker Muscular Dystrophy Carrier;JACC: Basic to Translational Science;2023-06

4. Modeling of Fabry disease nephropathy using patient derived human induced pluripotent stem cells and kidney organoid system;Journal of Translational Medicine;2023-02-22

5. Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives;REGUL MECH BIOSYST;2023